» Articles » PMID: 17454884

Lack of Association Between Genetic Polymorphisms in Cytokine Genes and Disease Expression in Patients with Hereditary Non-polyposis Colorectal Cancer

Overview
Publisher Informa Healthcare
Specialty Gastroenterology
Date 2007 Apr 25
PMID 17454884
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Hereditary non-polyposis colorectal cancer (HNPCC) is caused by germline mutations in DNA mismatch repair (MMR) genes and is characterized by familial aggregations of early-onset epithelial cancers. Inflammatory cells produce an attractive environment for tumour growth since reactive oxygen and nitrogen species generated by inflammatory cytokine induction can cause damage to DNA and proteins. In this study the objective was to investigate single nucleotide polymorphisms (SNPs) in cytokine genes to assess their impact on disease expression in individuals diagnosed with HNPCC.

Material And Methods: DNA samples from 220 participants diagnosed with HNPCC were genotyped for SNPs in IL-6, IL-1beta, TNF-alpha, IFN-gamma, IL-10, IL-4 and IL-1RN. The association between the polymorphisms and disease characteristics, i.e. affected or unaffected with colorectal cancer (CRC) and age of diagnosis of CRC, was tested with the Pearson chi2 test and by Kaplan-Meier survival analysis.

Results: There was no significant difference between CRC patients and unaffected MMR gene mutation carriers for any of the SNPs studied and the Kaplan-Meier survival analysis showed no significant difference between age of diagnosis of CRC and genotype.

Conclusions: The SNPs selected for this study do not appear to modify disease expression in HNPCC. Given the complexity of the inflammatory response, the limited number of SNPs studied does not rule out the notion that other cytokine polymorphisms could act as disease modifiers of disease expression in HNPCC.

Citing Articles

The Effect of IL-6 174G > C Gene Polymorphism on Gastrointestinal Cancer: a Systematic Review and Meta-analysis.

Darvishi N, Salari N, Bokaee S, Shohaimi S, Mohammadi M Indian J Surg Oncol. 2023; 14(2):411-422.

PMID: 37324283 PMC: 10267097. DOI: 10.1007/s13193-022-01698-1.


Association of Interleukin-10 Polymorphisms with Susceptibility to Colorectal Cancer and Gastric Cancer: an Updated Meta-analysis Based on 106 Studies.

Zare M, Dastgheib S, Tabatabaie S, Asadian F, Setayesh S, Mirjalili H J Gastrointest Cancer. 2021; 53(4):1066-1082.

PMID: 34694592 DOI: 10.1007/s12029-021-00685-z.


Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer.

Song X, Traub B, Shi J, Kornmann M Int J Mol Sci. 2021; 22(2).

PMID: 33450900 PMC: 7828336. DOI: 10.3390/ijms22020727.


The association of three promoter polymorphisms in interleukin-10 gene with the risk for colorectal cancer and hepatocellular carcinoma: A meta-analysis.

Shi Y, Zhao D, Wang Y, Li X, Ji M, Jiang D Sci Rep. 2016; 6:30809.

PMID: 27489033 PMC: 4973248. DOI: 10.1038/srep30809.


A Causal Role of Genetically Elevated Circulating Interleukin-10 in the Development of Digestive Cancers: Evidence from Mendelian Randomization Analysis Based on 29,307 Subjects.

Niu W, Pang Q, Lin T, Wang Z, Zhang J, Tai M Medicine (Baltimore). 2016; 95(7):e2799.

PMID: 26886630 PMC: 4998630. DOI: 10.1097/MD.0000000000002799.